MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517059246 A) filed by Epics Therapeutics, Gosselies, Belgium, on June 20, for 'piperidine derivatives as mettl3 inhibitors.'
Inventor(s) include Dutheuil, Guillaume; Fraser, Graeme; Sorlet, Catherine; Oukoloff, Killian; Lenoir, Francois; and Korac, Julien.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds of formula (I), (I) or pharmaceutically acceptable salts and/or solvates thereof, wherein m, n, R1, R2, R3, R4, R5, L, Ar1 and Ar2 are as defined in the claims, which are useful as inhibitors of METTL3 (N6-adenosine-methlytransferase subunit) activity, in particular for the treatment of proliferative diseases such as cancers."
The patent application was internationally filed on Jan. 19, 2024, under International application No.PCT/EP2024/051219.
Disclaimer: Curated by HT Syndication.
